HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stewart, S. Articles by Manning, J. Search for Related Content PubMed PubMed Citation Articles by Stewart, S. Articles by Manning, J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 93, 551-554, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement

S Stewart, D Cianciotta, C Alexson and J Manning

Thirty children less than 18 years of age underwent cardiac valve replacement with a prosthetic valve between 1967 and 1984 and have been followed up for a mean of 6 years (range 1 to 17 years). Their mean age at the time of operation was 13 years (range 6 to 17 years). All patients were begun on a regimen of warfarin before hospital discharge. One major and four minor bleeding episodes occurred in 211 patient- years of warfarin therapy, an incidence of 2.3 per 100 patient-years. Three of those five episodes occurred in patients who were receiving excessively anticoagulation or who were participating in physical activities inappropriate for a patient on warfarin therapy. Thus, the majority of the bleeding episodes were preventable. There were five thromboembolic events in 211 patient-years, an incidence of 2.3 per 100 patient-years. Three of those five patients had intentionally stopped their warfarin therapy. The majority of thromboembolic episodes, like the bleeding episodes, were preventable. Eight teenage patients were noncompliant with the warfarin therapy. More than one third of that group experienced a thromboembolic event, an incidence of 5.5 per 100 patient-years (55 patient-years). Twenty-two patients adhered to the warfarin regimen and only two (9%) of them had a thromboembolic event, an incidence of 1.3 per 100 patient-years (156 patient-years). Warfarin therapy presented no greater risk of serious bleeding to this pediatric age group than it does to an adult age group. The incidence of thromboembolism among these patients was less than that which is generally reported for adult patients. Discontinuation of or noncompliance with warfarin therapy substantially increased the risk of thromboembolism. Continuous warfarin therapy is recommended for every child after prosthetic valve replacement.

This article has been cited by other articles:

				P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF]

				J. S. Tweddell, A. N. Pelech, P. C. Frommelt, R. D.B. Jaquiss, G. M. Hoffman, K. A. Mussatto, and S. B. Litwin Complex aortic valve repair as a durable and effective alternative to valve replacement in children with aortic valve disease J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 551 - 558. [Abstract] [Full Text] [PDF]

				P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. D. Michelson Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 645S - 687S. [Abstract] [Full Text] [PDF]

				R. G. Seipelt, A. Franke, J. F. Vazquez-Jimenez, P. Hanrath, G. von Bernuth, B. J. Messmer, and E. G. Muhler Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches Ann. Thorac. Surg., August 1, 2002; 74(2): 556 - 562. [Abstract] [Full Text] [PDF]

				P. Monagle, A. D. Michelson, E. Bovill, and M. Andrew Antithrombotic Therapy in Children Chest, January 1, 2001; 119 (2009): 344S - 370S. [Full Text] [PDF]

				W. Streif, M. Andrew, V. Marzinotto, P. Massicotte, A.K.C. Chan, J.A. Julian, and L. Mitchell Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients Blood, November 1, 1999; 94(9): 3007 - 3014. [Abstract] [Full Text] [PDF]

				S. M. Bradley, R. M. Sade, F. A. Crawford Jr, and M. R. Stroud Anticoagulation in Children With Mechanical Valve Prostheses Ann. Thorac. Surg., July 1, 1997; 64(1): 30 - 34. [Abstract] [Full Text]